Biodesix (BDSX) Invested Capital (2019 - 2025)
Biodesix (BDSX) has disclosed Invested Capital for 7 consecutive years, with -$2.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 111.81% year-over-year to -$2.5 million, compared with a TTM value of -$2.5 million through Dec 2025, down 111.81%, and an annual FY2025 reading of -$2.5 million, down 111.81% over the prior year.
- Invested Capital was -$2.5 million for Q4 2025 at Biodesix, down from -$1.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $42.1 million in Q2 2024 and bottomed at -$2.5 million in Q4 2025.
- Average Invested Capital over 5 years is $19.8 million, with a median of $19.4 million recorded in 2023.
- The sharpest move saw Invested Capital soared 456.26% in 2024, then tumbled 111.81% in 2025.
- Year by year, Invested Capital stood at $37.5 million in 2021, then fell by 17.45% to $30.9 million in 2022, then dropped by 14.57% to $26.4 million in 2023, then dropped by 21.03% to $20.9 million in 2024, then crashed by 111.81% to -$2.5 million in 2025.
- Business Quant data shows Invested Capital for BDSX at -$2.5 million in Q4 2025, -$1.7 million in Q3 2025, and $1.1 million in Q2 2025.